Primary Site >> Stomach Cancer
Gene >> GDF15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Helicobacter pylori antibiotic sensitivity by microdilution]. PMID: 15881743 |
Ref: Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. PMID: 12907645 |
Ref: Proapoptotic activity of NAG-1 is cell type specific and not related to COX-2 expression. PMID: 16699947 |
Ref: Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway. PMID: 17257745 Ref: Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. PMID: 17568183 Ref: Current multidisciplinary treatment of gastric cancer. PMID: 17694808 Ref: Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide. PMID: 17959037 |
Ref: Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. PMID: 18258606 Ref: Expression of nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) inversely correlates with tumor progression in gastric adenomas and carcinomas. PMID: 18264720 Ref: Serum bFGF concentrations in gastric cancer patients. PMID: 18447253 |
Ref: Gene expression profiling in TWIST-depleted gastric cancer cells. PMID: 19051271 Ref: Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers. PMID: 19133249 Ref: Pseudolaric acid B-induced apoptosis through p53-dependent pathway in human gastric carcinoma cells. PMID: 19219727 Ref: General changes in hemostasis in gastric cancer. PMID: 19507648 Ref: Local changes in hemostasis in patients with gastric cancer. PMID: 19507661 Ref: Activities of adenosine deaminase and 5'-nucleotidase in cancereous and non-cancereous human gastric tissues. PMID: 19711828 Ref: Increase in the circulating level of hepatocyte growth factor in pancreatic cancer patients. PMID: 20017454 Ref: [Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene]. PMID: 20067113 |
Ref: Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. PMID: 20104227 |
Ref: Troglitazone induces apoptosis in gastric cancer cells through the NAG-1 pathway. PMID: 21461570 |
Ref: Incorporating breath holding and image guidance in the adjuvant gastric cancer radiotherapy: a dosimetric study. PMID: 22716276 |
Ref: Palliative treatment of the advanced gastric cancer by means of surgery and HIPEC. PMID: 24329514 |
Ref: Variations in NAG-1 expression of human gastric carcinoma and normal gastric tissues. PMID: 24348798 Ref: Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance? PMID: 24586342 Ref: Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer. PMID: 24947260 |
Ref: Downregulation of growth differentiation factor-15 in trichostatin A-induced apoptosis could play a role in progression of gastric cancer. PMID: 26339382 |
Ref: Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation. PMID: 26892343 Ref: MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers. PMID: 26967326 Ref: S100A4 influences cancer stem cell-like properties of MGC803 gastric cancer cells by regulating GDF15 expression. PMID: 27278086 |
Ref: Correlation between GDF15, MMP7 and gastric cancer and its prognosis. PMID: 28239815 Ref: CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer. PMID: 29262584 |
Ref: miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2. PMID: 29342841 Ref: Author Correction: Comparison of quality of life between Billroth-capital I, Ukrainian and Roux-en-Y anastomosis after distal gastrectomy for gastric cancer: A randomized controlled trial. PMID: 29692422 Ref: Author Correction: A proteomic landscape of diffuse-type gastric cancer. PMID: 29739932 Ref: Correction: Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1. PMID: 30013076 Ref: Author Correction: Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer. PMID: 30171186 |